Your browser doesn't support javascript.
loading
Evaluation of intravenous and subcutaneous administration of a novel, excipient-free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasia.
Selting, Kim A; Bechtel, Sandra M; Espinosa, Jahna; Henry, Carolyn J; Tate, Deborah; Bryan, Jeffrey N; Rajewski, Lian; Flesner, Brian K; Decedue, Charles; Baltezor, Michael.
Afiliação
  • Selting KA; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri.
  • Bechtel SM; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri.
  • Espinosa J; Crititech, Inc., Lawrence, Kansas.
  • Henry CJ; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri.
  • Tate D; Department of Internal Medicine, University of Missouri, Columbia, Missouri.
  • Bryan JN; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri.
  • Rajewski L; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri.
  • Flesner BK; Biotechnology Innovation and Optimization Center, University of Kansas, Lawrence, Kansas.
  • Decedue C; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri.
  • Baltezor M; Crititech, Inc., Lawrence, Kansas.
Vet Comp Oncol ; 16(4): 650-657, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30182530

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paclitaxel / Doenças do Cão / Recidiva Local de Neoplasia / Antineoplásicos Fitogênicos Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paclitaxel / Doenças do Cão / Recidiva Local de Neoplasia / Antineoplásicos Fitogênicos Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article